Evidence map›Paper›PMID 36138434›Full record

ReviewInfectious diseases of poverty2022

Interventions pathways to reduce tuberculosis-related stigma: a literature review and conceptual framework.

Charlotte Nuttall, Ahmad Fuady, Holly Nuttall, Kritika Dixit, Muchtaruddin Mansyur, Tom Wingfield

Open access · goldAbstract readReview
In one paragraph

Review in Infectious diseases of poverty, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Managing tuberculosis infection among migrants from high-incidence tuberculosis countries: challenges, strategies and recommendations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 5 countries.

Charlotte Nuttall *Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK.
Ahmad Fuady *Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, 10310, Jakarta, Indonesia.ORCID http://orcid.org/0000-0003-0030-0524
Holly NuttallDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK.
Kritika DixitSocial Medicine, Infectious Diseases, and Migration (SIM) Group, Department of Public Health Sciences, Karolinska Institute, 10653, Stockholm, Sweden.
Muchtaruddin MansyurDepartment of Community Medicine, Faculty of Medicine, Universitas Indonesia, 10310, Jakarta, Indonesia.
Tom WingfieldDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK. Tom.Wingfield@lstmed.ac.uk.ORCID https://orcid.org/0000-0001-8433-6887
University of Liverpool · GBErasmus MC · NLNepal Medical College Teaching Hospital · NPUniversity of Indonesia · ID

Funding

Medical Research Council MR/V004832/1
6 · The paper itself

Abstract

backgroundPrevention of tuberculosis (TB)-related stigma is vital to achieving the World Health Organisation's End TB Strategy target of eliminating TB. However, the process and impact evaluation of interventions to reduce TB-stigma are limited. This literature review aimed to examine the quality, design, implementation challenges, and successes of TB-stigma intervention studies and create a novel conceptual framework of pathways to TB-stigma reduction.

methodWe searched relevant articles recorded in four scientific databases from 1999 to 2022, using pre-defined inclusion and exclusion criteria, supplemented by the snowball method and complementary grey literature searches. We assessed the quality of studies using the Crowe Critical Appraisal Tool, then reviewed study characteristics, data on stigma measurement tools used, and interventions implemented, and designed a conceptual framework to illustrate the pathways to TB-stigma reduction in the interventions identified.

resultsOf 14,259 articles identified, eleven met inclusion criteria, of which three were high quality. TB-stigma reduction interventions consisted mainly of education and psychosocial support targeted predominantly toward three key populations: people with TB, healthcare workers, and the public. No psychosocial interventions for people with TB set TB-stigma reduction as their primary or co-primary aim. Eight studies on healthcare workers and the public reported a decrease in TB-stigma attributed to the interventions. Despite the benefits, the interventions were limited by a dearth of validated stigma measurement tools. Three of eight studies with quantitative stigma measurement questionnaires had not been previously validated among people with TB. No qualitative studies used previously validated methods or tools to qualitatively evaluate stigma. On the basis of these findings, we generated a conceptual framework that mapped the population targeted, interventions delivered, and their potential effects on reducing TB-stigma towards and experienced by people with TB and healthcare workers involved in TB care.

conclusionsInterpretation of the limited evidence on interventions to reduce TB-stigma is hampered by the heterogeneity of stigma measurement tools, intervention design, and outcome measures. Our novel conceptual framework will support mapping of the pathways to impacts of TB-stigma reduction interventions.

Indexed as

Social StigmaTuberculosisGlobal HealthHealth PersonnelHumansQualitative ResearchInterventionStigmaStigma measurement toolTuberculosis

Identifiers

PMID36138434
PMCPMC9502609
OpenAlexW4296807421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.